These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17082659)

  • 21. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.
    Kono K; Kawaida H; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Fujii H
    Cancer Immunol Immunother; 2006 Sep; 55(9):1064-71. PubMed ID: 16328385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.
    Yokokawa J; Cereda V; Remondo C; Gulley JL; Arlen PM; Schlom J; Tsang KY
    Clin Cancer Res; 2008 Feb; 14(4):1032-40. PubMed ID: 18281535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis.
    Lewkowicz N; Lewkowicz P; Dzitko K; Kur B; Tarkowski M; Kurnatowska A; Tchórzewski H
    J Oral Pathol Med; 2008 Sep; 37(8):454-61. PubMed ID: 18318707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of frequency of peripheral blood CD4+; CD25(high);Tregs and CD4+; CD25(low);T cells and expression of PD-1 in SLE and RA patients].
    Niu Q; Huang ZC; Cai B; Wang LL; Feng WH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):23-5. PubMed ID: 21208558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis.
    Rashid Chehreh Bargh S; Tafakhori A; Masoumi F; Rahmani F; Ahmadi M; Namdar A; Azimi M; Tavasolian P; Habibi S; Zamani B; Maserrat M; Sadr M; Noorbakhsh F; Rezaei N
    Ir J Med Sci; 2018 Nov; 187(4):1065-1071. PubMed ID: 29574662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased peripheral CD4+CD25high Treg in prostate cancer patients is correlated with PSA.
    Akin Y; Koksoy S; Yucel S; Erdogru T; Baykara M
    Saudi Med J; 2011 Oct; 32(10):1003-8. PubMed ID: 22008917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus.
    Lee HY; Hong YK; Yun HJ; Kim YM; Kim JR; Yoo WH
    Rheumatology (Oxford); 2008 Jun; 47(6):789-94. PubMed ID: 18388146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
    Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
    Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue.
    Valdman A; Jaraj SJ; Compérat E; Charlotte F; Roupret M; Pisa P; Egevad L
    APMIS; 2010 May; 118(5):360-5. PubMed ID: 20477811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of Foxp3 in CD4+CD25high Treg cells of neonatal cord blood].
    Tang J; Li BQ; Ruan J; Zhang LJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr; 24(4):365-7. PubMed ID: 18394345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (99) Tc-methylene diphosphonate improves rheumatoid arthritis disease activity by increasing the frequency of peripheral γδ T cells and CD4(+) CD25(+) Foxp3(+) Tregs.
    Su D; Shen M; Gu B; Wang X; Wang D; Li X; Sun L
    Int J Rheum Dis; 2016 Jun; 19(6):586-93. PubMed ID: 24467668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells.
    Grindebacke H; Stenstad H; Quiding-Järbrink M; Waldenström J; Adlerberth I; Wold AE; Rudin A
    J Immunol; 2009 Oct; 183(7):4360-70. PubMed ID: 19734224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol.
    Mjösberg J; Svensson J; Johansson E; Hellström L; Casas R; Jenmalm MC; Boij R; Matthiesen L; Jönsson JI; Berg G; Ernerudh J
    J Immunol; 2009 Jul; 183(1):759-69. PubMed ID: 19535629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4
    Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.
    Okita R; Yamaguchi Y; Ohara M; Hironaka K; Okawaki M; Nagamine I; Ikeda T; Emi A; Hihara J; Okada M
    Int J Oncol; 2009 Feb; 34(2):563-72. PubMed ID: 19148493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
    Teng L; Liu L; Su Y; Yuan X; Li J; Fu Q; Chen S; Wang C
    J Surg Res; 2011 Dec; 171(2):797-806. PubMed ID: 20538297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.